Category: Fluvoxamine

Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies

Posted on | Posted on John Murphy | Leave a Comment on Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies

Suo-wen Xu, Iqra Ilyas & Jian-ping Weng Acta Pharmacologica Sinica volume 44, pages695–709 (2023) Nature Abstract The fight against coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is still raging. However, the pathophysiology of acute and post-acute manifestations of COVID-19 (long COVID-19) is understudied. Endothelial cells are sentinels lining the innermost layer of blood vessel that gatekeep micro- and macro-vascular health by […]

Can This Common Medication Help Reduce The Risk Of Long COVID?

Posted on | Posted on John Murphy | Leave a Comment on Can This Common Medication Help Reduce The Risk Of Long COVID?

A recent study suggests that the treatment may help some high-risk people following an infection. By Casey Clark Aug 29, 2023 It seems like every time you turn on the news or open your phone, new information about COVID-19 pops up. Most of this information is pertinent to the latest variant EG.5, also called “Eris,” but recently, other more […]